166 related articles for article (PubMed ID: 30687751)
1. The Immunogenicity of the C Fragment of Tetanus Neurotoxin in Production of Tetanus Antitoxin.
Yu R; Ji C; Xu J; Wang D; Fang T; Jing Y; Kwang-Fu Shen C; Chen W
Biomed Res Int; 2018; 2018():6057348. PubMed ID: 30687751
[TBL] [Abstract][Full Text] [Related]
2. Studies on the antibody composition and neutralizing activity of tetanus antitoxin sera from various species of animals in relation to the antigenic substructure of the tetanus toxin molecule.
Matsuda M; Makinaga G; Hirai T
Biken J; 1983 Dec; 26(4):133-43. PubMed ID: 6204634
[TBL] [Abstract][Full Text] [Related]
3. Tetanus Neurotoxin Neutralizing Antibodies Screened from a Human Immune scFv Antibody Phage Display Library.
Wang H; Yu R; Fang T; Yu T; Chi X; Zhang X; Liu S; Fu L; Yu C; Chen W
Toxins (Basel); 2016 Sep; 8(9):. PubMed ID: 27626445
[TBL] [Abstract][Full Text] [Related]
4. Quantitation of commercial equine tetanus antitoxin by competitive enzyme-linked immunosorbent assay.
Kolbe DR; Clough NE
FEMS Immunol Med Microbiol; 1999 Jul; 24(3):313-7. PubMed ID: 10397316
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and immunoprotection of the functional TL-HN fragment derived from tetanus toxin.
Liu XY; Wei DK; Li ZY; Lu JS; Xie XM; Yu YZ; Pang XB
Vaccine; 2023 Nov; 41(46):6834-6841. PubMed ID: 37816654
[TBL] [Abstract][Full Text] [Related]
6. Human monoclonal ScFv that inhibits cellular entry and metalloprotease activity of tetanus neurotoxin.
Indrawattana N; Sookrung N; Kulkeaw K; Seesuay W; Kongngoen T; Chongsa-nguan M; Tungtrongchitr A; Chaicumpa W
Asian Pac J Allergy Immunol; 2010 Mar; 28(1):85-93. PubMed ID: 20527521
[TBL] [Abstract][Full Text] [Related]
7. Transcutaneous delivery of tetanus toxin Hc fragment induces superior tetanus toxin neutralizing antibody response compared to tetanus toxoid.
Johnston L; Mawas F; Tierney R; Qazi O; Fairweather N; Sesardic D
Hum Vaccin; 2009 Apr; 5(4):230-6. PubMed ID: 18948742
[TBL] [Abstract][Full Text] [Related]
8. Enhanced expression of soluble recombinant tetanus neurotoxin Hc in Escherichia coli as a tetanus vaccine candidate.
Yu R; Hou L; Yu C; Liu S; Ren J; Fang T; Zhang X; Chen W
Immunobiology; 2011 Apr; 216(4):485-90. PubMed ID: 20888666
[TBL] [Abstract][Full Text] [Related]
9. A conformational change of C fragment of tetanus neurotoxin reduces its ganglioside-binding activity but does not destroy its immunogenicity.
Yu R; Yi S; Yu C; Fang T; Liu S; Yu T; Song X; Fu L; Hou L; Chen W
Clin Vaccine Immunol; 2011 Oct; 18(10):1668-72. PubMed ID: 21813664
[TBL] [Abstract][Full Text] [Related]
10. Characterization of neutralizing monoclonal antibodies directed against tetanus toxin fragment C.
Yousefi M; Tahmasebi F; Younesi V; Razavi A; Khoshnoodi J; Bayat AA; Abbasi E; Rabbani H; Jeddi-Tehrani M; Shokri F
J Immunotoxicol; 2014; 11(1):28-34. PubMed ID: 23369087
[TBL] [Abstract][Full Text] [Related]
11. Key protection factors against tetanus: Anti-tetanus toxin antibody affinity and its ability to prevent tetanus toxin - ganglioside interaction.
Lukić I; Marinković E; Filipović A; Krnjaja O; Kosanović D; Inić-Kanada A; Stojanović M
Toxicon; 2015 Sep; 103():135-44. PubMed ID: 26140841
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the immune response to papain digestion products of tetanus toxin.
Helting TB; Nau HH
Acta Pathol Microbiol Immunol Scand C; 1984 Feb; 92(1):59-63. PubMed ID: 6711309
[TBL] [Abstract][Full Text] [Related]
13. Characterization of neutralizing chimeric heavy-chain antibodies against tetanus toxin.
Cheng K; Lu J; Guo J; Wang R; Chen L; Wang X; Jiang Y; Li Y; Xu C; Kang Q; Qiaerxie G; Du P; Gao C; Yu Y; Yang Z; Wang W
Hum Vaccin Immunother; 2024 Dec; 20(1):2366641. PubMed ID: 38934499
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of tetanus toxin neutralization by native human monoclonal antibodies.
Wang Y; Wu C; Yu J; Lin S; Liu T; Zan L; Li N; Hong P; Wang X; Jia Z; Li J; Wang Y; Zhang M; Yuan X; Li C; Xu W; Zheng W; Wang X; Liao HX
Cell Rep; 2021 May; 35(5):109070. PubMed ID: 33951441
[TBL] [Abstract][Full Text] [Related]
15. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
Gupta RK; Siber GR
Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of tetanus antitoxin titers of sera from immunized mice and guinea pigs determined by toxin neutralization test and enzyme-linked immunosorbent assay.
Gupta RK; Siber GR
Biologicals; 1994 Sep; 22(3):215-9. PubMed ID: 7811454
[TBL] [Abstract][Full Text] [Related]
17. Novel neutralizing human monoclonal antibodies against tetanus neurotoxin.
Minamitani T; Kiyose K; Otsubo R; Ito T; Akiba H; Furuta RA; Inoue T; Tsumoto K; Satake M; Yasui T
Sci Rep; 2021 Jun; 11(1):12134. PubMed ID: 34108521
[TBL] [Abstract][Full Text] [Related]
18. Design and construction of immune phage antibody library against Tetanus neurotoxin: Production of single chain antibody fragments.
Sadreddini S; Seifi-Najmi M; Ghasemi B; Kafil HS; Alinejad V; Sadreddini S; Younesi V; Jadidi-Niaragh F; Yousefi M
Hum Antibodies; 2015 Dec; 23(3-4):73-9. PubMed ID: 27472865
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of a neutralizing murine monoclonal antibody against tetanus toxin.
Li Y; Chen Y; Cui J; Liu D; Zhang W; Xue C; Xiong X; Liu G; Chen H
J Immunol Methods; 2023 Feb; 513():113427. PubMed ID: 36652969
[TBL] [Abstract][Full Text] [Related]
20. Comparative human and mouse antibody responses against tetanus toxin at clonal level.
Yousefi M; Younesi V; Bayat AA; Jadidi-Niaragh F; Abbasi E; Razavi A; Khosravi-Eghbal R; Asgarian-Omran H; Shokri F
J Immunotoxicol; 2016; 13(2):243-8. PubMed ID: 25990600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
